TP53 and ovarian serous carcinoma: For instance, ReACp53, a cell-penetrating peptide, can inhibit mutp53 aggregation and rescue p53 function in cancer cells and organoids derived from high-grade serous ovarian carcinomas, an aggressive cancer characterized by ubiquitous p53 mutations (Soragni et al., 2016).